Management of hyperlipidemia in women with diabetes.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
R H Knopp

Abstract

To review gender-related factors in coronary artery disease, possible mechanisms for increased atherogenesis in women with diabetes, and potential therapeutic strategies for hyperlipidemia. Pertinent published studies and personal experiences are discussed, and lipoprotein profiles are outlined. In the normal population, the increase in atherosclerotic vascular disease with aging in women lags behind that in men by 10 to 15 years. With the presence of diabetes, however, the atherosclerotic changes are similar in men and women. Several studies have substantiated that triglyceride levels are a stronger risk factor than cholesterol in men and women with diabetes who have coronary artery disease. In general, hypertriglyceridemia is a stronger risk factor for cardiovascular disease in women than in men. Gender differences in lipid levels can be explained physiologically by the presence of estrogen in female patients, which accelerates the rate of metabolism of lipoproteins and, in a setting of insulin deficiency, induces hypertriglyceridemia. Dietary measures and various classes of drugs, including reductase inhibitors, are used alone or in combination for management of the combined hyperlipidemia typically found in subjects with in...Continue Reading

References

Jan 1, 1979·Circulation·W B Kannel, D L McGee
Feb 1, 1990·Diabetes Care·A Garg, S M Grundy
Jun 1, 1988·American Journal of Obstetrics and Gynecology·W P Castelli
Oct 11, 1984·The New England Journal of Medicine·C E WaldenE Strandness
Nov 1, 1995·JAMA : the Journal of the American Medical Association·D S SiscovickL H Kushi
Oct 1, 1994·Diabetes Care·S M HaffnerB V Howard
Feb 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·D H Blankenhorn, H N Hodis
Jan 10, 1996·JAMA : the Journal of the American Medical Association·R G Bakker-ArkemaD M Black
Jul 1, 1997·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·A J Garber

❮ Previous
Next ❯

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Related Papers

JAMA : the Journal of the American Medical Association
S B Eysmann, P S Douglas
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
S A M SaidJ S Bos
© 2022 Meta ULC. All rights reserved